Sex-Dependent Antipsychotic Capacity of 17β-Estradiol in the Latent Inhibition Model: A Typical Antipsychotic Drug in Both Sexes, Atypical Antipsychotic Drug in Males (original) (raw)

• Akhondzadeh S, Nejatisafa AA, Amini H, Mohammadi MR, Larijani B, Kashani L et al (2003). Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 27: 1007–1012.
  Article CAS PubMed Google Scholar
• Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL et al (2006). Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 55: 103–115.
  Article CAS PubMed Google Scholar
• Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E et al (1999). Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290: 1393–1408.
  CAS PubMed Google Scholar
• Arad M, Weiner I (2008). Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women? Psychoneuroendocrinology 33: 1401–1410.
  Article PubMed Google Scholar
• Arad M, Weiner I (2009). Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone. Psychopharmacology (Berl) 206: 731–740.
  Article CAS Google Scholar
• Arad M, Weiner I (2010). Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis? Neuropsychopharmacology 35: 1570–1582.
  Article CAS PubMed PubMed Central Google Scholar
• Arvin M, Fedorkova L, Disshon KA, Dluzen DE, Leipheimer RE (2000). Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques. Brain Res 872: 160–171.
  CAS PubMed Google Scholar
• Auer RN (1996). Effect of age and sex on _N_-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27: 743–746.
  Article CAS PubMed Google Scholar
• Bakshi VP, Swerdlow NR, Geyer MA (1994). Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271: 787–794.
  CAS PubMed Google Scholar
• Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I (2009). Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology 34: 1753–1763.
  Article CAS PubMed Google Scholar
• Barber PV, Arnold AG, Evans G (1976). Recurrent hormone dependent chorea: effects of oestrogens and progestogens. Clin Endocrinol (Oxf) 5: 291–293.
  Article CAS Google Scholar
• Barch DM, Carter CS (2008). Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative. Schizophr Bull 34: 613–618.
  Article PubMed PubMed Central Google Scholar
• Barnes P, Staal V, Muir J, Good MA (2006). 17-beta estradiol administration attenuates deficits in sustained and divided attention in young ovariectomized rats and aged acyclic female rats. Behav Neurosci 120: 1225–1234.
  Article CAS PubMed Google Scholar
• Barrett SL, Bell R, Watson D, King DJ (2004). Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers. J Psychopharmacol 18: 156–172.
  Article CAS PubMed Google Scholar
• Baruch I, Hemsley DR, Gray JA (1988). Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 176: 598–606.
  Article CAS PubMed Google Scholar
• Becker JB (1999). Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64: 803–812.
  Article CAS PubMed Google Scholar
• Becker JB, Beer ME (1986). The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components. Behav Brain Res 19: 27–33.
  Article CAS PubMed Google Scholar
• Becker JB, Rudick CN (1999). Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol Biochem Behav 64: 53–57.
  Article CAS PubMed Google Scholar
• Bedard P, Boucher R, Di Paolo T, Labrie F (1983). Biphasic effect of estradiol and domperidone on lingual dyskinesia in monkeys. Exp Neurol 82: 172–182.
  Article CAS PubMed Google Scholar
• Bedard P, Dankova J, Boucher R, Langelier P (1978). Effect of estrogens on apomorphine-induced circling behavior in the rat. Can J Physiol Pharmacol 56: 538–541.
  Article CAS PubMed Google Scholar
• Bedard P, Langelier P, Villeneuve A (1977). Oestrogens and extrapyramidal system. Lancet 2: 1367–1368.
  Article CAS PubMed Google Scholar
• Bedard PJ, Malouin F, Dipaolo T, Labrie F (1982). Estradiol, TRH and striatal dopaminergic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 6: 555–561.
  Article CAS PubMed Google Scholar
• Bergemann N, Mundt C, Parzer P, Pakrasi M, Eckstein-Mannsperger U, Haisch S et al (2005). Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study. Schizophr Res 74: 125–134.
  Article PubMed Google Scholar
• Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D et al (2008). Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology (Berl) 202: 385–396.
  Article CAS Google Scholar
• Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D et al (2009). Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology (Berl) 202: 385–396.
  Article CAS Google Scholar
• Braunstein-Bercovitz H, Rammsayer T, Gibbons H, Lubow RE (2002). Latent inhibition deficits in high-schizotypal normals: symptom-specific or anxiety-related? Schizophr Res 53: 109–121.
  Article CAS PubMed Google Scholar
• Buckland PR, D’Souza U, Maher NA, McGuffin P (1997). The effects of antipsychotic drugs on the mRNA levels of serotonin 5HT2A and 5HT2C receptors. Brain Res Mol Brain Res 48: 45–52.
  Article CAS PubMed Google Scholar
• Carlsson A, Waters N, Carlsson ML (1999). Neurotransmitter interactions in schizophrenia—therapeutic implications. Biol Psychiatry 46: 1388–1395.
  Article CAS PubMed Google Scholar
• Carlsson M, Carlsson A (1990a). Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272–276.
  Article CAS PubMed Google Scholar
• Carlsson M, Carlsson A (1990b). Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull 16: 425–432.
  Article CAS PubMed Google Scholar
• Chavez C, Gogos A, Jones ME, van den Buuse M (2009). Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters. Psychopharmacology (Berl) 206: 267–279.
  Article CAS Google Scholar
• Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, van den Buuse M (2010). The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res 1321: 51–59.
  Article CAS PubMed Google Scholar
• Chiodo LA, Caggiula AR, Saller CF (1979). Estrogen increases both spiperone-induced catalepsy and brain levels of [3H]spiperone in the rat. Brain Res 172: 360–366.
  Article CAS PubMed Google Scholar
• Cyr M, Bosse R, Di Paolo T (1998). Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex. Neuroscience 83: 829–836.
  Article CAS PubMed Google Scholar
• Cyr M, Calon F, Morissette M, Di Paolo T (2002). Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 27: 12–27.
  PubMed PubMed Central Google Scholar
• Cyr M, Ghribi O, Di Paolo T (2000). Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol 12: 445–452.
  Article CAS PubMed Google Scholar
• Cyr M, Ghribi O, Thibault C, Morissette M, Landry M, Di Paolo T (2001). Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res Brain Res Rev 37: 153–161.
  Article CAS PubMed Google Scholar
• Daniel JM, Bohacek J (2010). The critical period hypothesis of estrogen effects on cognition: insights from basic research. Biochim Biophys Acta (e pub ahead of print).
• Daniel JM, Dohanich GP (2001). Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J Neurosci 21: 6949–6956.
  Article CAS PubMed PubMed Central Google Scholar
• de Olmos S, Bueno A, Bender C, Lorenzo A, de Olmos J (2008). Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat. Brain Struct Funct 213: 229–238.
  Article CAS PubMed Google Scholar
• De Ryck M, Hruska RE, Silbergeld EK (1982). Estrogen and haloperidol-induced versus handling-related catalepsy in male rats. Pharmacol Biochem Behav 17: 1027–1035.
  Article CAS PubMed Google Scholar
• Di Paolo T (1994). Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27–41.
  Article CAS PubMed Google Scholar
• Di Paolo T, Carmichael R, Labrie F, Raynaud JP (1979). Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain. Mol Cell Endocrinol 16: 99–112.
  Article CAS PubMed Google Scholar
• Di Paolo T, Poyet P, Labrie F (1981). Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73: 105–106.
  Article CAS PubMed Google Scholar
• Disshon KA, Boja JW, Dluzen DE (1998). Inhibition of striatal dopamine transporter activity by 17beta-estradiol. Eur J Pharmacol 345: 207–211.
  Article CAS PubMed Google Scholar
• Dluzen D, Horstink M (2003). Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies. Endocrine 21: 67–75.
  Article CAS PubMed Google Scholar
• Dribben W, Nemmers B, Nardi A, Taylor G, Olney J, Farber N (2003). Chronic but not acute estradiol treatment protects against the neurodegenerative effects of _N_-methyl-D-aspartate receptor antagonists. Endocrine 21: 53–58.
  Article CAS PubMed Google Scholar
• Dunn LA, Atwater GE, Kilts CD (1993). Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl) 112: 315–323.
  Article CAS Google Scholar
• Earley CJ, Leonard BE (1978). Behavioural studies on the effects of d-amphetamine and estradiol benzoate alone and in combination. Psychopharmacology (Berl) 56: 179–183.
  Article CAS Google Scholar
• El-Bakri NK, Islam A, Zhu S, Elhassan A, Mohammed A, Winblad B et al (2004). Effects of estrogen and progesterone treatment on rat hippocampal NMDA receptors: relationship to Morris water maze performance. J Cell Mol Med 8: 537–544.
  Article CAS PubMed PubMed Central Google Scholar
• Euvrard C, Labrie F, Boissier JR (1979). Effect of moxestrol on haloperidol-induced changes in striatal acetylcholine levels and dopamine turn-over. Commun Psychopharmacol 3: 329–334.
  CAS PubMed Google Scholar
• Euvrard C, Oberlander C, Boissier JR (1980). Antidopaminergic effect of estrogens at the striatal level. J Pharmacol Exp Ther 214: 179–185.
  CAS PubMed Google Scholar
• Fattore L, Altea S, Fratta W (2008). Sex differences in drug addiction: a review of animal and human studies. Womens Health (Lond Engl) 4: 51–65.
  Article CAS Google Scholar
• Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R (1998). Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764–775.
  Article CAS PubMed Google Scholar
• Fix AS, Wozniak DF, Truex LL, McEwen M, Miller JP, Olney JW (1995). Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res 696: 194–204.
  Article CAS PubMed Google Scholar
• Frick KM (2009). Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here? Horm Behav 55: 2–23.
  Article CAS PubMed Google Scholar
• Gaisler-Salomon I, Diamant L, Rubin C, Weiner I (2008). Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl) 196: 255–267.
  Article CAS Google Scholar
• Gaisler-Salomon I, Weiner I (2003). Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology (Berl) 166: 333–342.
  Article CAS Google Scholar
• Galea LA, Wide JK, Barr AM (2001). Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 122: 1–9.
  Article CAS PubMed Google Scholar
• Gazzaley AH, Weiland NG, McEwen BS, Morrison JH (1996). Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci 16: 6830–6838.
  Article CAS PubMed PubMed Central Google Scholar
• Gibbs RB, Burke AM, Johnson DA (1998). Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm Behav 34: 112–125.
  Article CAS PubMed Google Scholar
• Gogos A, Kwek P, Chavez C, van den Buuse M (2010). Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors. J Pharmacol Exp Ther 333: 218–227.
  Article CAS PubMed Google Scholar
• Gogos A, Nathan PJ, Guille V, Croft RJ, van den Buuse M (2006). Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31: 885–889.
  Article CAS PubMed Google Scholar
• Gordon JH (1980). Modulation of apomorphine-induced stereotypy by estrogen: time course and dose response. Brain Res Bull 5: 679–682.
  Article CAS PubMed Google Scholar
• Gordon JH, Diamond BI (1981). Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 16: 365–371.
  CAS PubMed Google Scholar
• Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991). The neuropsychology of schizophrenia. Behav Brain Sci 14: 1–84.
  Article Google Scholar
• Gray JA, Joseph MH, Hemsley DR, Young AM, Warburton EC, Boulenguez P et al (1995a). The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res 71: 19–31.
  Article CAS PubMed Google Scholar
• Gray JA, Moran PM, Grigoryan G, Peters SL, Young AM, Joseph MH (1997). Latent inhibition: the nucleus accumbens connection revisited. Behav Brain Res 88: 27–34.
  Article CAS PubMed Google Scholar
• Gray NS, Hemsley DR, Gray JA (1992a). Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiatr Brain res 1: 83–89.
  Google Scholar
• Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA (1992b). Abolition of latent inhibition by a single 5mg dose of d-amphetamine in man. Psychopharmacology (Berl) 107: 425–430.
  Article CAS Google Scholar
• Gray NS, Pilowsky LS, Gray JA, Kerwin RW (1995b). Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res 17: 95–107.
  Article CAS PubMed Google Scholar
• Hafner H (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28 (Suppl 2): 17–54.
  Article PubMed Google Scholar
• Hafner H, Behrens S, De Vry J, Gattaz WF (1991). An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 38: 125–134.
  Article CAS PubMed Google Scholar
• Hafner H, Riecher A, Maurer K, Loffler W, Munk-Jorgensen P, Stromgren E (1989). How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med 19: 903–918.
  Article CAS PubMed Google Scholar
• Harvey PD, Rabinowitz J, Eerdekens M, Davidson M (2005). Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry 162: 1888–1895.
  Article PubMed Google Scholar
• Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G et al (2005). D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 57: 577–585.
  Article CAS PubMed Google Scholar
• Honack D, Loscher W (1993). Sex differences in NMDA receptor mediated responses in rats. Brain Res 620: 167–170.
  Article CAS PubMed Google Scholar
• Hruska RE, Silbergeld EK (1980). Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model. Science 208: 1466–1468.
  Article CAS PubMed Google Scholar
• Huber TJ, Borsutzky M, Schneider U, Emrich HM (2004). Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 109: 269–274.
  Article CAS PubMed Google Scholar
• Huber TJ, Rollnik J, Wilhelms J, von zur Muhlen A, Emrich HM, Schneider U (2001). Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26: 27–35.
  Article CAS PubMed Google Scholar
• Huber TJ, Tettenborn C, Leifke E, Emrich HM (2005). Sex hormones in psychotic men. Psychoneuroendocrinology 30: 111–114.
  Article CAS PubMed Google Scholar
• Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301–1308.
  Article CAS PubMed Google Scholar
• Jentsch JD, Taylor JR (2001). Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 24: 66–74.
  Article CAS PubMed Google Scholar
• Joseph MH, Peters SL, Moran PM, Grigoryan GA, Young AM, Gray JA (2000). Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience 101: 921–930.
  Article CAS PubMed Google Scholar
• Kapur S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13–23.
  Article PubMed Google Scholar
• Kapur S, Mizrahi R, Li M (2005). From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79: 59–68.
  Article PubMed Google Scholar
• Kitamura N, Araya R, Kudoh M, Kishida H, Kimura T, Murayama M et al (2009). Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency. PLoS One 4: e5159.
  Article PubMed PubMed Central CAS Google Scholar
• Korhonen S, Saarijarvi S, Aito M (1995). Successful estradiol treatment of psychotic symptoms in the premenstrual phase: a case report. Acta Psychiatr Scand 92: 237–238.
  Article CAS PubMed Google Scholar
• Krystal JH, Bennett A, Abi-Saab D, Belger A, Karper LP, D′Souza DC et al (2000). Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry 47: 137–143.
  Article CAS PubMed Google Scholar
• Krystal JH, D′Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 169: 215–233.
  Article CAS Google Scholar
• Kulkarni J (2009). Oestrogen—a new treatment approach for schizophrenia? Med J Aust 190: S37–S38.
  PubMed Google Scholar
• Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C et al (2008a). Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65: 955–960.
  Article PubMed Google Scholar
• Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996). A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 20: 247–252.
  Article CAS PubMed Google Scholar
• Kulkarni J, Gurvich C, Gilbert H, Mehmedbegovic F, Mu L, Marston N et al (2008b). Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust N Z J Psychiatry 42: 83–88.
  Article PubMed Google Scholar
• Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J et al (2001). Estrogen—a potential treatment for schizophrenia. Schizophr Res 48: 137–144.
  Article CAS PubMed Google Scholar
• Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9–19.
  Article CAS PubMed Google Scholar
• Lipina T, Labrie V, Weiner I, Roder J (2005). Modulators of the glycine site on NMDA receptors, D: -serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology (Berl) 179: 54–67.
  Article CAS Google Scholar
• Lubow RE . Latent Inhibition and Conditioned Attention Theory. Cambridge University Press: Cambridge University Press, 1989.
• Mackintosh NJ (1975). A theory of attention: Variations in the associability of stimuli with reinforcement. Psychol Rev 82: 276–298.
  Article Google Scholar
• Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141–150.
  Article CAS PubMed Google Scholar
• Marcondes FK, Bianchi FJ, Tanno AP (2002). Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62: 609–614.
  Article CAS PubMed Google Scholar
• McCartan D, Bell R, Green JF, Campbell C, Trimble K, Pickering A et al (2001). The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers. J Psychopharmacol 15: 96–104.
  Article CAS PubMed Google Scholar
• McDermott JL (1993). Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats. Brain Res 606: 118–125.
  Article CAS PubMed Google Scholar
• McEwen BS, Alves SE (1999). Estrogen actions in the central nervous system. Endocr Rev 20: 279–307.
  CAS PubMed Google Scholar
• Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921–2927.
  Article CAS PubMed PubMed Central Google Scholar
• Moghaddam B, Jackson ME (2003). Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003: 131–137.
  Article CAS PubMed Google Scholar
• Morissette M, Al Sweidi S, Callier S, Di Paolo T (2008). Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 290: 60–69.
  Article CAS PubMed Google Scholar
• Morissette M, Di Paolo T (1993). Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J Neurochem 60: 1876–1883.
  Article CAS PubMed Google Scholar
• Mortimer AM (2007). Relationship between estrogen and schizophrenia. Expert Rev Neurother 7: 45–55.
  Article CAS PubMed Google Scholar
• Naik SR, Kelkar MR, Sheth UK (1978). Attenuation of stereotyped behaviour by sex steroids. Psychopharmacology (Berl) 57: 211–214.
  Article CAS Google Scholar
• Nicoletti F, Ferrara N, Patti F, Viglianesi M, Rampello L, Bianchi A et al (1983). Influence of sex steroids and prolactin on haloperidol-induced catalepsy. Brain Res 279: 352–358.
  Article CAS PubMed Google Scholar
• Nilsson M, Waters S, Waters N, Carlsson A, Carlsson ML (2001). A behavioural pattern analysis of hypoglutamatergic mice—effects of four different antipsychotic agents. J Neural Transm 108: 1181–1196.
  Article CAS PubMed Google Scholar
• Nofrey BS, Ben-Shahar OM, Brake WG (2008). Estrogen abolishes latent inhibition in ovariectomized female rats. Brain Cogn 66: 156–160.
  Article PubMed Google Scholar
• Packard MG, Kohlmaier JR, Alexander GM (1996). Posttraining intrahippocampal estradiol injections enhance spatial memory in male rats: interaction with cholinergic systems. Behav Neurosci 110: 626–632.
  Article CAS PubMed Google Scholar
• Palermo-Neto J, Dorce VA (1990). Influences of estrogen and/or progesterone on some dopamine related behavior in rats. Gen Pharmacol 21: 83–87.
  Article CAS PubMed Google Scholar
• Palsson E, Klamer D, Wass C, Archer T, Engel JA, Svensson L (2005). The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning. Behav Brain Res 157: 139–146.
  Article CAS PubMed Google Scholar
• Peris J, Decambre N, Coleman-Hardee ML, Simpkins JW (1991). Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res 566: 255–264.
  Article CAS PubMed Google Scholar
• Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE et al (2005). Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol Psychiatry 58: 812–824.
  Article CAS PubMed Google Scholar
• Perlman WR, Webster MJ, Kleinman JE, Weickert CS (2004). Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 56: 844–852.
  Article CAS PubMed Google Scholar
• Rascle C, Mazas O, Vaiva G, Tournant M, Raybois O, Goudemand M et al (2001). Clinical features of latent inhibition in schizophrenia. Schizophr Res 51: 149–161.
  Article CAS PubMed Google Scholar
• Riddoch D, Jefferson M, Bickerstaff ER (1971). Chorea and the oral contraceptives. Br Med J 4: 217–218.
  Article CAS PubMed PubMed Central Google Scholar
• Riecher-Rossler A (2002). Oestrogen effects in schizophrenia and their potential therapeutic implications—review. Arch Womens Ment Health 5: 111–118.
  Article CAS PubMed Google Scholar
• Riecher-Rossler A, de Geyter C (2007). The forthcoming role of treatment with oestrogens in mental health. Swiss Med Wkly 137: 565–572.
  PubMed Google Scholar
• Riecher-Rossler A, Hafner H (1993). Schizophrenia and oestrogens—is there an association? Eur Arch Psychiatry Clin Neurosci 242: 323–328.
  Article CAS PubMed Google Scholar
• Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R (1994). Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20: 203–214.
  Article CAS PubMed Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333.
  Article CAS PubMed Google Scholar
• Salgado JV, Hetem LA, Vidal M, Graeff FG, Danion JM, Sandner G (2000). Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans. Behav Brain Res 117: 61–67.
  Article CAS PubMed Google Scholar
• Sams-Dodd F (1996). Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7: 3–23.
  CAS PubMed Google Scholar
• Seeman MV, Lang M (1990). The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185–194.
  Article CAS PubMed Google Scholar
• Segarra AC, Agosto-Rivera JL, Febo M, Lugo-Escobar N, Menéndez-Delmestre R, Puig-Ramos A et al (2009). Estradiol: a key biological substrate mediating the response to cocaine in female rats. Horm Behav 58: 33–43.
  Article PubMed PubMed Central CAS Google Scholar
• Shadach E, Feldon J, Weiner I (1999). Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. Int J Neuropsychopharmacol 2: 283–291.
  Article CAS PubMed Google Scholar
• Sherwin BB, Chertkow H, Schipper H, Nasreddine Z (2009). A randomized controlled trial of estrogen treatment in men with mild cognitive impairment. Neurobiol Aging (e pub ahead of print).
• Shieh KR, Yang SC (2008). Effects of estradiol on the stimulation of dopamine turnover in mesolimbic and nigrostriatal systems by cocaine- and amphetamine-regulated transcript peptide in female rats. Neuroscience 154: 1589–1597.
  Article CAS PubMed Google Scholar
• Smith A, Li M, Becker S, Kapur S (2006). Dopamine, prediction error and associative learning: a model-based account. Network 17: 61–84.
  Article PubMed Google Scholar
• Soderstrom I, Strand M, Ingridsson AC, Nasic S, Olsson T (2009). 17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia. Eur J Neurosci 29: 1215–1224.
  Article PubMed Google Scholar
• Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED et al (2006). Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295: 1647–1657.
  Article CAS PubMed Google Scholar
• Stevenson JC (2009). Hormone replacement therapy and cardiovascular disease revisited. Menopause Int 15: 55–57.
  Article PubMed Google Scholar
• Summer BE, Fink G (1995). Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 54: 15–20.
  Article CAS PubMed Google Scholar
• Sumner BE, Fink G (1997). The density of 5-hydoxytryptamine2A receptors in forebrain is increased at pro-oestrus in intact female rats. Neurosci Lett 234: 7–10.
  Article CAS PubMed Google Scholar
• Sumner BE, Fink G (1998). Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res Mol Brain Res 59: 205–214.
  Article CAS PubMed Google Scholar
• Sutcliffe JS, Marshall KM, Neill JC (2007). Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav Brain Res 177: 117–125.
  Article CAS PubMed Google Scholar
• Sutcliffe JS, Rhaman F, Marshall KM, Neill JC (2008). Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats. J Psychopharmacol 22: 918–922.
  Article CAS PubMed Google Scholar
• Svensson TH (2000). Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Brain Res Rev 31: 320–329.
  Article CAS PubMed Google Scholar
• Swerdlow NR, Bakshi V, Geyer MA (1996). Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 279: 1290–1299.
  CAS PubMed Google Scholar
• Swerdlow NR, Koob GF (1987). Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 10: 197–245.
  Article Google Scholar
• Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP (2003). Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology (Berl) 169: 314–320.
  Article CAS Google Scholar
• Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Minassian A et al (2005). Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm. Schizophr Res 72: 169–183.
  Article PubMed Google Scholar
• Tamminga CA (1998). Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12: 21–36.
  Article CAS PubMed Google Scholar
• Teyler TJ, Vardaris RM, Lewis D, Rawitch AB (1980). Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science 209: 1017–1018.
  Article CAS PubMed Google Scholar
• Thompson TL, Moss RL (1994). Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J Neurochem 62: 1750–1756.
  Article CAS PubMed Google Scholar
• Thornton JC, Dawe S, Lee C, Capstick C, Corr PJ, Cotter P et al (1996). Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl) 127: 164–173.
  Article CAS Google Scholar
• Van den Buuse M, Eikelis N (2001). Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425: 33–41.
  Article CAS PubMed Google Scholar
• van der Meulen JA, Bilbija L, Joosten RN, de Bruin JP, Feenstra MG (2003). The NMDA-receptor antagonist MK-801 selectively disrupts reversal learning in rats. Neuroreport 14: 2225–2228.
  Article CAS PubMed Google Scholar
• Walf AA, Frye CA (2009). Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol Behav 99: 169–174.
  Article PubMed PubMed Central CAS Google Scholar
• Warburton EC, Mitchell SN, Joseph MH (1996). Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition. Behav Pharmacol 7: 119–129.
  Article CAS PubMed Google Scholar
• Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V et al (2008). Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17: 2293–2309.
  Article CAS PubMed PubMed Central Google Scholar
• Weiland NG (1992). Estradiol selectively regulates agonist binding sites on the _N_-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131: 662–668.
  CAS PubMed Google Scholar
• Weiner I (2003). The ‘two-headed’ latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) 169: 257–297.
  Article CAS Google Scholar
• Weiner I, Arad M (2009). Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res 204: 369–386.
  Article CAS PubMed Google Scholar
• Weiner I, Feldon J (1987). Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology (Berl) 91: 248–253.
  CAS Google Scholar
• Weiner I, Joel D (2002). Dopamine in schizophrenia: dysfunctional information processing in basal ganglia-thalamocortical split circuits. In: Di Chiara G (ed). Handbook of Experimental Pharmacology. Springer: Berlin. pp 418–472.
  Google Scholar
• Weiner I, Schiller D, Gaisler-Salomon I (2003). Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology 28: 499–509.
  Article CAS PubMed Google Scholar
• Williams JH, Wellman NA, Geaney DP, Cowen PJ, Feldon J, Rawlins JN (1996). Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people. Biol Psychiatry 40: 1135–1143.
  Article CAS PubMed Google Scholar
• Williams JH, Wellman NA, Geaney DP, Feldon J, Cowen PJ, Rawlins JN (1997). Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology (Berl) 133: 262–268.
  Article CAS Google Scholar
• Wong J, Weickert CS (2009). Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J Biol Chem 284: 18824–18832.
  Article CAS PubMed PubMed Central Google Scholar
• Woolley CS, Schwartzkroin PA (1998). Hormonal effects on the brain. Epilepsia 39 (Suppl 8): S2–S8.
  Article PubMed Google Scholar
• Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997). Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17: 1848–1859.
  Article CAS PubMed PubMed Central Google Scholar
• Wozniak DF, Dikranian K, Ishimaru MJ, Nardi A, Corso TD, Tenkova T et al (1998). Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease. Neurobiol Dis 5: 305–322.
  Article CAS PubMed Google Scholar
• Yu PL, Wu CI, Lee TS, Pan WH, Wang PS, Wang SW (2009). Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats. J Cell Biochem 108: 1318–1324.
  Article CAS PubMed Google Scholar
• Zhou W, Cunningham KA, Thomas ML (2002). Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res Mol Brain Res 100: 75–83.
  Article CAS PubMed Google Scholar